Post on 27-Mar-2015
transcript
A brief overview of ART services at QECH, Malawi
Kudzala Aub. MMEDsc. Student
Sr. Lead ART Clinician/ HIV Medicine Registrar
OOutlineutline
•Current Challenges
•Genetic Barriers of Regimens
•Rationale for the clinical decision
Challenges
•Drug shortage problems
•Especially 3TC, NVP
•Laboratory back up
Challenges
Quantity versus Quality
Demand versus Supply
Shortage of health care personnel
Toxicity of the 1st line regime
Lancet 2000
- expensive- complicated- logistics- adherence
2000 1 clinician 25 patients Fee-paying
Malawi ART clinics 2002
TM&IH 2005
- Many lost to follow up- ATN - Poor adherence
Personal financeDrug shortage
2004 ART SCALE UP PROGRAMME
HIV Unit Ministry of HealthHIV Unit Ministry of Health
Global fund to fight AIDS-TB-Malaria
National ART Guidelines
Training of > 2000 clinicians and nurses
2004 ART SCALE UP PROGRAMME
HIV Unit Ministry of HealthHIV Unit Ministry of Health
Establishments of ART clinics within the existing HCS
PUBLIC HEALTH APPROACH TO ART
Large number of ART in RLS
Standardized than individualized
Simplified monitoring of treatment
Predominant use of Clinical Officers and Nurses
PUBLIC HEALTH PUBLIC HEALTH APPROACH TO ART APPROACH TO ART
ART to be free of charge
Follow experiences of the national TB programme
Standardised monitoring and reporting
PUBLIC HEALTH APPROACH TO ART
Quarterly supervision
Strong drug logistics
Harries et al - BMJ 2004
Cost of ARV drugs
Netherlands:
• Truvada®
• Stocrin®
USD 10,000 / year
Malawi: Triomune 30®
USD 100 / year
Malawi ART clinics 20082002
2010
5 377
270,000 patients started ART
9% children 9% children 60% females 60% females
• 93% on the same first line regimen
• 5% on alternative first line regimen
• <1% on second line regimen
Major Changes to the National ART Programme in 2011
PMTCT, Paediatric, Adult ART integration
Strategic phasing out of Stavudine
CD4 threshold increase
CHALLENGESCHALLENGES
Quantity versus Quality
Demand versus Supply
Shortage of health care personnel
Toxicity of the first line regime
CHALLENGESCHALLENGES
Early ART mortality
ART failure
ART delivery Infrastructure
Limited Laboratory Back up
DRUG SUPPLY DRUG SUPPLY CONTINUESCONTINUES
Possible reasons for the Drug Possible reasons for the Drug Shortage?Shortage?
•Increased # of clients on non standard regime.
•Inadequate financing or under-budgeting.
•Inefficiencies in supply and distribution chain.
SELECTED POINT SELECTED POINT EXAMPLES OF DRUG EXAMPLES OF DRUG
SUPPLYSUPPLY•Drug shortage is the main problem
•June 2010 3TC = 0, NVP = 117
•August 2010 3TC = 0, NVP = 0
•Sept. 2010 3TC = 55, NVP = 100
Conclusion Conclusion
Malawi ART Scale up Malawi ART Scale up Programme Programme
•Successful under difficult circumstances using public health approachLarge number of patients on ARTFavourable outcomes
• Many challenges
•Current Challenges
AcknowledgementsAcknowledgements
Joep van Oosterhout, M.D., PhD, Joep van Oosterhout, M.D., PhD, Associate Professor of Internal Associate Professor of Internal Medicine, University of Malawi, Medicine, University of Malawi, College of MedicineCollege of Medicine
AcknowledgementsAcknowledgements
James Blessings Mwambene, James Blessings Mwambene, Dip.Clin.Med, PGD(Mgt studies), Dip.Clin.Med, PGD(Mgt studies), The ART Outreach Coordinator, The ART Outreach Coordinator, Queen Elizabeth Central Hospital, Queen Elizabeth Central Hospital, MalawiMalawi
AcknowledgementsAcknowledgements
Cooper Nyirenda, M.D.,MMED, Cooper Nyirenda, M.D.,MMED, FRCP, Chief Govt. Physician, FRCP, Chief Govt. Physician, Queen Elizabeth Central HospitalQueen Elizabeth Central Hospital